✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹158 Cr.
P/E
85.69

Key Ratios

Market cap
Market cap
158 Cr
PE
PE
85.69
Prom Holding
Prom Holding
52.18 %
ROE (%)
ROE (%)
18.57
ROCE (%)
ROCE (%)
17.93
Div Yield (%)
Div Yield (%)
-
Sales
Sales
19.28 Cr
OPM (%)
OPM (%)
17.14 %
Debt to Equity
Debt to Equity
0.63
About
Auro Laboratories Limited, founded in 1992 in Mumbai, is a manufacturer of Active Pharmaceutic… Read more
Low
156
52W Range
High
300
  • Auro Laboratories
  • Astonea Labs
  • Sotac Pharmaceutical

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Auro Laboratories Ltd. Business

Auro Laboratories Limited is a pharmaceutical company specializing in manufacturing Active Pharmaceutical Ingredients, Intermediates, and Generic Formulations, with a primary focus on Anti-Diabetic Drugs.

Auro Laboratories major competitors are Bal Pharma, Astonea Labs, Amwill Health Care, BDH Inds, Sotac Pharmaceutical, Vaishali Pharma, IndoAmerican Advance.
Market Cap of Auro Laboratories is ₹158 Crs.
While the median market cap of its peers are ₹157 Crs.

Auro Laboratories seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material